EDIT-401 in Adults Who Require Additional Lowering of Low-Density Lipoprotein Cholesterol (LDL-C) | MicrobiomeTrials← Back to trialsNCT07894887
EDIT-401 in Adults Who Require Additional Lowering of Low-Density Lipoprotein Cholesterol (LDL-C)
RecruitingPHASE1, PHASE2INTERVENTIONAL
Trial Details
Start: 2026-11Est. Completion: 2029-06
Enrollment target: 56 participants Locations- Clinical Study Center, Charlestown, New South Wales, Australia
- Clinical Study Center, Perth, Western Australia, Australia
Other microbiome trials you might be interested in
Heterozygous Familial Hypercholesterolemia (HeFH)Homozygous Familial Hypercholesterolemia (HoFH)Familial Hypercholesterolemia
The goal of this clinical trial is to identify different types of Familial Hypercholesterolemia (FH) in infants and newb…
Madison, United StatesEst. completion Feb 14, 2029
Heterozygous Familial Hypercholesterolemia (HeFH)
This study is designed to learn if enlicitide decanoate is safe and effective to treat children and adolescents with het…
Wilmington, United StatesEst. completion Dec 4, 2033